dopamine - CISMeF

Preferred Label : dopamine;

MeSH definition : One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.;

MeSH synonym : 3,4 dihydroxyphenethylamine; 4-(2-aminoethyl)-1,2-benzenediol; hydroxytyramine; 3,4-dihydroxyphenethylamine;

CISMeF synonym : 62-31-7 (Dopamine hydrochloride);

MeSH hyponym : dopamine hydrochloride; intropin; Hydrochloride, Dopamine;

MeSH CAS label : 1,2-Benzenediol, 4-(2-aminoethyl)-;

MeSH Related Number : dopamine hydrochloride; 51-61-6 (Dopamine); 62-31-7 (HCl); 7L3E358N9L;

Registry Number MeSH : 51-61-6;

Related CAS MeSH : 7L3E358N9L (Dopamine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Dopamine;

Codes EINECS : 200-110-0;

Is substance : O;

UNII : VTD58H1Z2X;

InChIKey : VYFYYTLLBUKUHU-UHFFFAOYSA-N;

Details

Origin ID

D004298;

UMLS CUI

C0013030;

ATC code(s)
- dopamine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- dopamine [Substance BNPC]
Currated CISMeF NLP mapping
- DOPamine [LOINC component]
- Dopamine [ICD-11 Extension code]
- Dopamine [ICHI extension code]
- Dopamine [SMS substance]
- Dopamine [NCIt concept]
- Dopamine [FMA entity]
- Dopamine (substance) [SNOMED CT concept]
- dopamine [SNOMED Notion]
- dopamine [Artificial nutrition thesaurus concept]
Indexing information
- 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone [MeSH Supplementary Concept]
- dopamine-E receptor [MeSH Supplementary Concept]
- dopamine-I receptor [MeSH Supplementary Concept]
- epinephrinechrome [MeSH Supplementary Concept]
- neurotensin (1-6) [MeSH Supplementary Concept]
- norepinephrinechrome [MeSH Supplementary Concept]
Pharmacological action(s)
- cardiotonic agents [MeSH Descriptor]
- dopamine agents [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
Record concept(s)
- dopamine [MeSH concept]
- dopamine hydrochloride [MeSH concept]
- intropin [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2 (3,4-dihydroxyphenyl)ethyl)dimethylselenonium [MeSH Supplementary Concept]
- (2-(3,4-dihydroxyphenyl)-2-oxoethyl)dimethylsulfonium [MeSH Supplementary Concept]
- (2-(3,4-dihydroxyphenyl)ethyl)dimethylsulfonium [MeSH Supplementary Concept]
- (2-(3,4-dimethoxyphenyl)ethyl)dimethylselenonium [MeSH Supplementary Concept]
- 1,2-dehydro-N-acetyldopamine [MeSH Supplementary Concept]
- 1,2-dehydro-N-beta-alanyldopamine [MeSH Supplementary Concept]
- 2-amino-N-(2-(3,4-dihydroxyphenyl)ethyl)-3-phenylpropionamide [MeSH Supplementary Concept]
- 2-chlorodopamine [MeSH Supplementary Concept]
- 2-fluorodopamine [MeSH Supplementary Concept]
- 3,4-dibenzoyl dopamine [MeSH Supplementary Concept]
- 3,4-dihydroxybenzylamine [MeSH Supplementary Concept]
- 3-O-methyl-alpha-methyldopamine [MeSH Supplementary Concept]
- 3-benzoyl dopamine [MeSH Supplementary Concept]
- 3-hydroxy-4-methoxyphenethylamine [MeSH Supplementary Concept]
- 3-methoxytyramine [MeSH Supplementary Concept]
- 3-methyl-N-oleoyldopamine [MeSH Supplementary Concept]
- 4-methyl-N-oleoyldopamine [MeSH Supplementary Concept]
- 5-S-cysteaminyldopamine [MeSH Supplementary Concept]
- 5-S-cysteinyldopamine [MeSH Supplementary Concept]
- 5-fluorodopamine [MeSH Supplementary Concept]
- 6,7-dihydroxy-N-cyanomethyl-1,2,3,4-tetrahydroisoquinoline [MeSH Supplementary Concept]
- 6-aminodopamine [MeSH Supplementary Concept]
- 6-fluorodopamine [MeSH Supplementary Concept]
- 6-mercaptodopamine [MeSH Supplementary Concept]
- 6-nitrodopamine [MeSH Supplementary Concept]
- 7-propyltheophylline dopamine [MeSH Supplementary Concept]
- BIM-23A761 [MeSH Supplementary Concept]
- BIM23B065 [MeSH Supplementary Concept]
- FPL 65447 [MeSH Supplementary Concept]
- IPX 750 [MeSH Supplementary Concept]
- N(beta)-alanyldopamine [MeSH Supplementary Concept]
- N,N-di-n-propyldopamine [MeSH Supplementary Concept]
- N,N-dimethyldopamine [MeSH Supplementary Concept]
- N-(3,4-methylenedioxycinnamoyl)dopamine [MeSH Supplementary Concept]
- N-(N-acetylmethionyl)dopamine [MeSH Supplementary Concept]
- N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine [MeSH Supplementary Concept]
- N-acetyl-3-O-methyldopamine [MeSH Supplementary Concept]
- N-acetyldopamine [MeSH Supplementary Concept]
- N-acetyldopamine quinone methide [MeSH Supplementary Concept]
- N-acetyldopamine-sulfate [MeSH Supplementary Concept]
- N-caffeoyldopamine [MeSH Supplementary Concept]
- N-coumaroyldopamine [MeSH Supplementary Concept]
- N-docosahexaenoyl dopamine [MeSH Supplementary Concept]
- N-feruloyl-3-methyldopamine [MeSH Supplementary Concept]
- N-isopropyldopamine [MeSH Supplementary Concept]
- N-linoleoyldopamine [MeSH Supplementary Concept]
- N-n-propyl-N-n-butyl-beta-dopamine [MeSH Supplementary Concept]
- N-nicotinoyl dopamine [MeSH Supplementary Concept]
- N-octanoyldopamine [MeSH Supplementary Concept]
- N-oleoyldopamine [MeSH Supplementary Concept]
- N-palmitoyl dopamine [MeSH Supplementary Concept]
- N-propyl-N-(6-(2-(3,5-dihydroxyphenyl)ethylamino)hexyl)-5,6-dihydroxy-1,2,3,4-tetrahydro-2-naphthylamine [MeSH Supplementary Concept]
- N-stearoyl-dopamine [MeSH Supplementary Concept]
- NMI 8739 [MeSH Supplementary Concept]
- TBR-760 [MeSH Supplementary Concept]
- alpha-methyl-6-aminodopamine [MeSH Supplementary Concept]
- arachidonyl dopamine [MeSH Supplementary Concept]
- aristomanoside [MeSH Supplementary Concept]
- aspongamide A [MeSH Supplementary Concept]
- benzedrine [MeSH Supplementary Concept]
- cicadamide A [MeSH Supplementary Concept]
- cicadamide B [MeSH Supplementary Concept]
- coryneine [MeSH Supplementary Concept]
- divesamide A [MeSH Supplementary Concept]
- divesamide B [MeSH Supplementary Concept]
- docarpamine [MeSH Supplementary Concept]
- dopamine 3-O-sulfate [MeSH Supplementary Concept]
- dopamine 4-O-sulfate [MeSH Supplementary Concept]
- dopamine dithiocarbamate [MeSH Supplementary Concept]
- dopamine glucuronide [MeSH Supplementary Concept]
- dopamine quinone [MeSH Supplementary Concept]
- dopamine, Gly-Pro-amide- [MeSH Supplementary Concept]
- dopamine, Lys-Pro-amide- [MeSH Supplementary Concept]
- dopamine, N-benzyloxycarboxyl-Lys-Pro-amide- [MeSH Supplementary Concept]
- dopamine-3-phosphate ester [MeSH Supplementary Concept]
- dopamine-4-phosphate ester [MeSH Supplementary Concept]
- dopamine-heptamethine cyanine dye [MeSH Supplementary Concept]
- dopexamine [MeSH Supplementary Concept]
- feruloyldopamine [MeSH Supplementary Concept]
- gamma-glutamyl dopamine [MeSH Supplementary Concept]
- mimosinamine [MeSH Supplementary Concept]
- myxillin A [MeSH Supplementary Concept]
- myxillin B [MeSH Supplementary Concept]
- myxillin C [MeSH Supplementary Concept]
- nitrodopamine-mPEG [MeSH Supplementary Concept]
- poly(acrylamide-co-dopamine methacrylamide) [MeSH Supplementary Concept]
- poly(dopamine methacrylate-co-2-methoxyetheyl acrylate) [MeSH Supplementary Concept]
- tensophoril [MeSH Supplementary Concept]
Related MeSH term(s)
- dopamine agonists [MeSH Descriptor]
- dopamine antagonists [MeSH Descriptor]
See also
- dihydroxyphenylalanine [MeSH Descriptor]
- dopamine agents [MeSH Descriptor]
- levodopa [MeSH Descriptor]
- receptors, dopamine [MeSH Descriptor]
See also (suggested by CISMeF)
- dopaminergic neurons [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- DOPamine [LOINC component]
- Dopamine [ICD-11 Extension code]
- Dopamine [FMA entity]
- Dopamine [NCIt concept]
- Dopamine (substance) [SNOMED CT concept]
- Product containing dopamine (medicinal product) [SNOMED CT concept]
- dopamine [ATC Code]
- dopamine [SNOMED Notion]
- dopamine [Substance BNPC]
- dopamine preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- Dopamine Hydrochloride [NCIt concept]
- Dopamine hydrochloride [Substance BNPC]
- Dopamine hydrochloride [SMS substance]
- Dopamine hydrochloride (substance) [SNOMED CT concept]
- dopamine [ATC Code]
- dopamine hydrochloride [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients